TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Shire PLC (ADR) (NASDAQ:SHPG) Investor Investigation Concerning Possible Violations Of Securities Laws Announced

  • If you purchased shares of Shire PLC (ADR) (NASDAQ:SHPG), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Shire PLC
Security
NASDAQ: SHPG

Summary

June 9, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Shire PLC (ADR) (NASDAQ:SHPG) shares over potential securities laws violations by Shire PLC and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Shire PLC (ADR) (NASDAQ:SHPG) concerning whether a series of statements by Shire PLC regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On June 7, 2017, Shire PLC revealed that it has stopped a U.S. study of Alpha-1 Antitrypsin (G1-ATT IV), its graft-versus-host disease treatment, and will hand over its Investigational New Drug application to Kamada Ltd. for additional testing

Shares of Shire PLC (ADR) (NASDAQ:SHPG) closed on June 9, 2017 at $165.02 per share.

Start Monitoring Your Investments